Dalpiciclib plus chidamide in HR + /HER2−advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trial

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-70650-6
Affiliations:
4
Authors:
15
Go to article
Institutions Authors Share
The People's Liberation Army General Hospital (PLAGH), China
9.000000
 0.60
Academy of Military Medical Sciences (AMMS), China
4.000000
 0.27
Hengrui, China
2.000000
 0.13
Interested in Oncology and Carcinogenesis?